Action grants on substances of human origin (SoHo) – Increase resilience, ensure continuity of supply and access to safe and high quality therapies, in particular in times of crisis
Summary
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Call
Detailed Call Description
Proposed measures and actions can be targeted at local/hospital level, regional/national level and supra-national/Union level. The measures and actions developed can be implemented by professionals, in collaboration with their national authorities as appropriate, across the Union. The work will aim to identify, share, assess and refine measures and actions taken and planned to mitigate the impact of the COVID-19 pandemic on safety, quality and accessibility of these therapies. The specific sub-sectors that will be supported include in particular: – blood and blood components (red blood cells, plasma); – organs (e.g. kidneys, liver, heart); – haematopoietic stem cells (bone marrow, cord blood); – gametes and embryos (for reproductive medicine); – tissues (corneas, heart valves).
Specific mandatory deliverables and/or milestones – Identification of good practices and guidance for clinics and healthcare systems where existing. – Development of good practices and guidance for clinics and healthcare systems. – Dissemination/exchange of good practices between medical/professional association across the Union and Member States authorities.
The applicants are required to include in their proposals additional specific action-level indicators which will be agreed with the HaDEA during the grant agreement preparation.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
60%
You can apply for a higher project funding rate (maximum 80%) if your project is of ‘exceptional utility’.
Eligibility For Participation Notes
- Professional medical societies (with professional members from hospitals, transplant centres and blood/tissue establishments across the Union).
- Representing experts in one or more healthcare specialities working with substances of human origin (SoHO, solid organs, haematopoietic stem cells, tissues, gametes, blood and blood components).
- Representing professionals in multiple EU Member States, having a strong relationship / collaboration with national/EU level authorities in the field of SoHO is neede .
Programme Category
EU Competitive ProgrammesTotal Budget
€3,500,000Thematic Categories
- Health
- Social Affairs & Human Rights
Eligibility for Participation
- Central Government
- Local Authorities
- Private Bodies
- State-owned Enterprises
Call Opening Date
29/07/2021Call Closing Date
15/09/2021National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
(Publish Date: 18/08/2021-for internal use only)
EU Contact Point
Stefan DE KEERSMAECKER
+32 2 298 46 80
stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
+32 2 298 39 78